Test
bernieecclestoned
But you are still forgetting the main point. EMA allows the nations under it to move drugs around
Not during shortages, the Single Market doesn't force anyone to share anything
If ou need a drug in one nation. That your helth service dosent want to provide. You can buy it yourself and import from another EU nation. As we could in 2019.
Without a prescription?
Now you cabnnot unless MHRA also covers it. So any drug created since 2020. Requires 2x the paperwork to even give you the option to buy.
The MHRA did the vast majority of the certification for the EMA...and the UK is still using the EU law and EMA to approve most medications
But, while the UK still relies on ema decisions, it has approved new cancer drugs more quickly
Brexit was also hailed as an opportunity for the UK to innovate alongside international partners, and here the UK has made progress. A number of schemes to fast-track promising drugs have borne fruit: in 2021, four innovative new cancer drugs were approved in the UK via an international scheme, Project Orbis, coordinated in the US with other non-EU partners. Additionally, the national Early Access to Medicines Scheme, which allows UK medics to prescribe before formal MHRA approval, saw another four medicines fast tracked for patients.
And the UK has the 7th largest share of the global pharma market. Do pharma suppliers not bother with approvals in Japan or Canada either?
Yep. But forms can be automated and policy can be written to make the UK more attractive for pharma
Other than things like Project Orbis?
https://www.gov.uk/guidance/guidance-on-project-orbis